Twine is working to develop targeted therapies to improve three key affected areas in people living with Duchenne muscular dystrophy (DMD) or related muscle diseases.
Company Details
- Founded
- 2023
- Address
- 701 E Pratt St, Baltimore,maryland 21202,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.twinetx.com
- Keywords
- Chevy Chase.
- HQ
- Baltimore, Maryland
Twine Therapeutics Questions
Twine Therapeutics's website is http://www.twinetx.com
Twine Therapeutics's LinkedIn profile is https://www.linkedin.com/company/twinetx
Twine Therapeutics's industry is
Biotechnology Research
Twine Therapeutics's top competitors are
Sereneuro Therapeutics,
Uncommon Cures®,
Astria Therapeutics, Inc.,
Rise Therapeutics,
Biofactura, Inc.,
Secretome Therapeutics,
Elixirgen Therapeutics, Inc.,
Lookhin4,
Athena Enzyme Systems,
Charter Preclinical Services.
Twine Therapeutics's categories are Biotechnology Research
Twine Therapeutics's founding year is 2023
